Last update 01 Nov 2024

Lung Rx Ltd.

Subsidiary Company|
United Kingdom

Overview

Basic Info

Introduction
LungRx Ltd., a subsidiary of United Therapeutics Corp., is a research and development company based in Chertsey, UK. The company specializes in conducting research and experiments in the fields of natural sciences and engineering.

Related

1
Drugs associated with Lung Rx Ltd.
Aviptadil
Target
VIPR1 x VIPR2
Mechanism
VIPR1 agonists [+1]
Active Org.
RELIEF THERAPEUTICS Holding SARELIEF THERAPEUTICS Holding SA [+2]
Originator Org.
United Therapeutics Corp.United Therapeutics Corp.
Active Indication
COVID-19 [+4]
Inactive Indication
Acute Lung Injury [+7]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
GE
First Approval Date27 Jul 2021
2
Clinical Trials associated with Lung Rx Ltd.
EUCTR2009-014246-29-IE / Not yet recruitingNot Applicable
A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy of Beraprost Sodium Modified Release (BPS-MR) in patients with pulmonary arterial hypertension (PAH)
EUCTR2008-003290-41-BE / Not yet recruitingNot Applicable
A Multi-center, open-label, multiple dose, dose finding study exploring the safety and tolerability of Beraprost Sodium Modified Release in PAH patients
100 Clinical Results associated with Lung Rx Ltd.
Login to view more data
0 Patents (Medical) associated with Lung Rx Ltd.
Login to view more data
100 Deals associated with Lung Rx Ltd.
Login to view more data
100 Translational Medicine associated with Lung Rx Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Aviptadil
 ( VIPR1 x VIPR2 )		Respiratory Distress Syndrome, Adult
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free